GLP-1 receptor agonists and atherosclerosis: a metabolic treatment for a cardiometabolic disease

European Heart Journal 2026

View at publisher
Authors: Georgios A. Georgiopoulos, Simon C Kraler, K S Stamatelopoulos
DOI: 10.1093/eurheartj/ehag075
Cited by: 2
References: 15

Abstract

This editorial refers to ‘Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers, and cardiovas

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Cardiovascular Risks and Lipoproteins Metabolism and Cancer

Publication details

Journal / source
European Heart Journal
Publisher
Oxford University Press (OUP)
Volume
47
Issue
28
Pages
3818–3820
Publication date
24 January 2026
Language
EN